Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
The viral magnetic cat-eye nail effect opened up a whole new world of opportunity for nail art: They catch the light in a way that gives nail designs a sense of fluid motion. This gives circular ...
Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Systems like OpenAI’s GPT-5 are accelerating research in math, biology and chemistry. But there is a debate over whether it can do that work on its own. Credit...Agnes Jonas Supported by By Cade Metz ...
This story contains descriptions of explicit sexual content and sexual violence. Elon Musk’s Grok chatbot has drawn outrage and calls for investigation after being used to flood X with “undressed” ...
Water has long been a source of renewable power. More than 2,000 years ago the Chinese used water wheels to grind grain and pound ore. In the 1700s water wheels kickstarted the Industrial Revolution ...
Generative AI is no longer a single thing. Ask, “What is the best generative AI tool for writing PR content?” or “Is keyword targeting as impossible as spinning straw into gold?,” and each engine will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results